HEADER MEMBRANE PROTEIN 27-MAY-10 3N7R TITLE CRYSTAL STRUCTURE OF THE ECTODOMAIN COMPLEX OF THE CGRP RECEPTOR, A TITLE 2 CLASS-B GPCR, REVEALS THE SITE OF DRUG ANTAGONISM COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 23-133; COMPND 5 SYNONYM: CGRP TYPE 1 RECEPTOR, CALCITONIN RECEPTOR-LIKE RECEPTOR; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; COMPND 9 CHAIN: C, D; COMPND 10 FRAGMENT: EXTRA-CELLULAR DOMAIN RESIDUES 26-117; COMPND 11 SYNONYM: CALCITONIN-RECEPTOR-LIKE RECEPTOR ACTIVITY-MODIFYING PROTEIN COMPND 12 1, CRLR ACTIVITY-MODIFYING PROTEIN 1; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CALCRL, CALRL_HUMAN, CGRPR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: RAMP1, RAMP1_HUMAN; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: ROSETTA DE3; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET28B KEYWDS GPCR, CLASS B GPCR, ANTAGONIST, OLCEGEPANT, TELCAGEPANT, MIGRAINE, KEYWDS 2 MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR E.TER HAAR REVDAT 4 26-OCT-22 3N7R 1 COMPND REMARK SEQADV HETNAM REVDAT 3 08-NOV-17 3N7R 1 REMARK REVDAT 2 22-SEP-10 3N7R 1 JRNL REVDAT 1 15-SEP-10 3N7R 0 JRNL AUTH E.TER HAAR,C.M.KOTH,N.ABDUL-MANAN,L.SWENSON,J.T.COLL, JRNL AUTH 2 J.A.LIPPKE,C.A.LEPRE,M.GARCIA-GUZMAN,J.M.MOORE JRNL TITL CRYSTAL STRUCTURE OF THE ECTODOMAIN COMPLEX OF THE CGRP JRNL TITL 2 RECEPTOR, A CLASS-B GPCR, REVEALS THE SITE OF DRUG JRNL TITL 3 ANTAGONISM. JRNL REF STRUCTURE V. 18 1083 2010 JRNL REFN ISSN 0969-2126 JRNL PMID 20826335 JRNL DOI 10.1016/J.STR.2010.05.014 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.9.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 10386 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.234 REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.730 REMARK 3 FREE R VALUE TEST SET COUNT : 491 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.24 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1310 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2704 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1255 REMARK 3 BIN R VALUE (WORKING SET) : 0.2708 REMARK 3 BIN FREE R VALUE : 0.2627 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 55 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2692 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 94 REMARK 3 SOLVENT ATOMS : 38 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 91.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -38.24910 REMARK 3 B22 (A**2) : 15.36280 REMARK 3 B33 (A**2) : 22.88630 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.542 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.881 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.841 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2891 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3943 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 877 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 96 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 451 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2891 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 1 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 360 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3362 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.03 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.69 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.10 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A32-A56 A63-A128 } REMARK 3 ORIGIN FOR THE GROUP (A): 22.4092 31.3066 67.4817 REMARK 3 T TENSOR REMARK 3 T11: 0.2466 T22: -0.1281 REMARK 3 T33: -0.1734 T12: 0.1497 REMARK 3 T13: -0.0210 T23: 0.0172 REMARK 3 L TENSOR REMARK 3 L11: 4.6966 L22: 0.6063 REMARK 3 L33: 2.0397 L12: -0.1063 REMARK 3 L13: 2.9104 L23: 2.2039 REMARK 3 S TENSOR REMARK 3 S11: -0.0531 S12: -0.1184 S13: 0.2959 REMARK 3 S21: 0.1401 S22: 0.0898 S23: 0.0269 REMARK 3 S31: -0.3962 S32: 0.0080 S33: -0.0367 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B33-B55 B60-B129 } REMARK 3 ORIGIN FOR THE GROUP (A): 36.9980 -0.4719 86.7207 REMARK 3 T TENSOR REMARK 3 T11: -0.1144 T22: -0.0859 REMARK 3 T33: -0.0464 T12: -0.0058 REMARK 3 T13: -0.0700 T23: -0.0260 REMARK 3 L TENSOR REMARK 3 L11: 2.5465 L22: 5.5889 REMARK 3 L33: 3.7900 L12: 2.8890 REMARK 3 L13: 1.3426 L23: 1.0621 REMARK 3 S TENSOR REMARK 3 S11: 0.0155 S12: 0.0400 S13: -0.3020 REMARK 3 S21: -0.0709 S22: 0.1796 S23: -0.1865 REMARK 3 S31: 0.1639 S32: 0.0536 S33: -0.1952 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { C26-C107 } REMARK 3 ORIGIN FOR THE GROUP (A): 38.0556 18.4806 84.5808 REMARK 3 T TENSOR REMARK 3 T11: -0.0841 T22: -0.0129 REMARK 3 T33: -0.0669 T12: -0.0057 REMARK 3 T13: 0.0119 T23: 0.0010 REMARK 3 L TENSOR REMARK 3 L11: 0.3491 L22: 3.4903 REMARK 3 L33: 3.5299 L12: 0.1584 REMARK 3 L13: 0.4730 L23: -1.2421 REMARK 3 S TENSOR REMARK 3 S11: 0.0595 S12: 0.0918 S13: 0.1080 REMARK 3 S21: -0.1306 S22: -0.1817 S23: 0.1263 REMARK 3 S31: -0.0784 S32: 0.1714 S33: 0.1222 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { D27-D106 } REMARK 3 ORIGIN FOR THE GROUP (A): 19.7425 18.6416 54.1447 REMARK 3 T TENSOR REMARK 3 T11: 0.0166 T22: -0.0733 REMARK 3 T33: -0.0378 T12: 0.0365 REMARK 3 T13: -0.0405 T23: 0.0422 REMARK 3 L TENSOR REMARK 3 L11: 1.2901 L22: 2.2374 REMARK 3 L33: 1.9442 L12: -0.4843 REMARK 3 L13: -1.1219 L23: 0.6304 REMARK 3 S TENSOR REMARK 3 S11: -0.0083 S12: 0.0598 S13: -0.1937 REMARK 3 S21: -0.1222 S22: 0.2375 S23: 0.0861 REMARK 3 S31: 0.0664 S32: -0.0886 S33: -0.2292 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3N7R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JUN-10. REMARK 100 THE DEPOSITION ID IS D_1000059486. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-AUG-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10420 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 73.6 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 12.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.30 REMARK 200 R MERGE FOR SHELL (I) : 0.43800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CLR/RAMP1 COMPLEX WAS MIXED WITH REMARK 280 OLCEGEPANT PRIOR TO CRYSTALLIZATION IN A 1:4 (PROTEIN : COMPOUND) REMARK 280 MOLAR RATIO. CRYSTALS WERE OBTAINED BY MIXING 0.6UL PROTEIN REMARK 280 WITH 0.3UL RESERVOIR SOLUTION CONTAINING 1-1.3M AMMONIUM SULFATE, REMARK 280 6-8% DIOXANE, 60-80MM MES PH 6.5, PLUS 0.4 M POTASSIUM REMARK 280 THIOCYANATE. TELCAGEPANT WAS SOAKED INTO THE LIGAND BINDING REMARK 280 SITE. THE CRYSTAL WAS TRANSFERRED TO 2.1M NAMALONATE (PH 7.0) REMARK 280 PRIOR TO FREEZING IN LIQUID NITROGEN., VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.63000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 66.63000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 38.97000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 59.10000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 38.97000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 59.10000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 66.63000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 38.97000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 59.10000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 66.63000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 38.97000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 59.10000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CHAINS A & D OR CHAINS B & C REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 19 REMARK 465 SER A 20 REMARK 465 HIS A 21 REMARK 465 MET A 22 REMARK 465 GLU A 23 REMARK 465 LEU A 24 REMARK 465 GLU A 25 REMARK 465 GLU A 26 REMARK 465 SER A 27 REMARK 465 PRO A 28 REMARK 465 GLU A 29 REMARK 465 ASP A 30 REMARK 465 SER A 31 REMARK 465 ILE A 57 REMARK 465 GLN A 58 REMARK 465 GLN A 59 REMARK 465 ALA A 60 REMARK 465 GLU A 61 REMARK 465 GLY A 62 REMARK 465 VAL A 129 REMARK 465 ASN A 130 REMARK 465 THR A 131 REMARK 465 HIS A 132 REMARK 465 GLU A 133 REMARK 465 GLY B 19 REMARK 465 SER B 20 REMARK 465 HIS B 21 REMARK 465 MET B 22 REMARK 465 GLU B 23 REMARK 465 LEU B 24 REMARK 465 GLU B 25 REMARK 465 GLU B 26 REMARK 465 SER B 27 REMARK 465 PRO B 28 REMARK 465 GLU B 29 REMARK 465 ASP B 30 REMARK 465 SER B 31 REMARK 465 ILE B 32 REMARK 465 GLN B 33 REMARK 465 PRO B 56 REMARK 465 ILE B 57 REMARK 465 GLN B 58 REMARK 465 GLN B 59 REMARK 465 ASN B 130 REMARK 465 THR B 131 REMARK 465 HIS B 132 REMARK 465 GLU B 133 REMARK 465 GLY C 22 REMARK 465 SER C 23 REMARK 465 HIS C 24 REMARK 465 MET C 25 REMARK 465 GLY C 108 REMARK 465 ARG C 109 REMARK 465 ALA C 110 REMARK 465 VAL C 111 REMARK 465 ARG C 112 REMARK 465 ASP C 113 REMARK 465 PRO C 114 REMARK 465 PRO C 115 REMARK 465 GLY C 116 REMARK 465 SER C 117 REMARK 465 GLY D 22 REMARK 465 SER D 23 REMARK 465 HIS D 24 REMARK 465 MET D 25 REMARK 465 ALA D 26 REMARK 465 SER D 107 REMARK 465 GLY D 108 REMARK 465 ARG D 109 REMARK 465 ALA D 110 REMARK 465 VAL D 111 REMARK 465 ARG D 112 REMARK 465 ASP D 113 REMARK 465 PRO D 114 REMARK 465 PRO D 115 REMARK 465 GLY D 116 REMARK 465 SER D 117 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 32 CB CG1 CG2 CD1 REMARK 470 LEU A 34 CG CD1 CD2 REMARK 470 ARG A 38 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 39 CG OD1 ND2 REMARK 470 LYS A 40 CG CD CE NZ REMARK 470 GLU A 47 CG CD OE1 OE2 REMARK 470 LYS A 51 CG CD CE NZ REMARK 470 VAL A 63 CB CG1 CG2 REMARK 470 TYR A 64 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 67 CG CD NE CZ NH1 NH2 REMARK 470 MET A 85 CG SD CE REMARK 470 LEU A 87 CG CD1 CD2 REMARK 470 ASP A 90 CG OD1 OD2 REMARK 470 ASP A 96 CB CG OD1 OD2 REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 ILE A 104 CG1 CG2 CD1 REMARK 470 GLN A 107 CG CD OE1 NE2 REMARK 470 LEU B 34 CB CG CD1 CD2 REMARK 470 ARG B 38 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 51 CG CD CE NZ REMARK 470 ALA B 60 CB REMARK 470 GLU B 61 CB CG CD OE1 OE2 REMARK 470 VAL B 63 CG1 CG2 REMARK 470 ASN B 66 CG OD1 ND2 REMARK 470 GLN B 93 CG CD OE1 NE2 REMARK 470 ILE B 104 CG1 CG2 CD1 REMARK 470 ASN B 128 CG OD1 ND2 REMARK 470 GLU C 78 CG CD OE1 OE2 REMARK 470 LYS C 79 CG CD CE NZ REMARK 470 ARG C 102 CG CD NE CZ NH1 NH2 REMARK 470 ILE C 106 CG1 CG2 CD1 REMARK 470 SER C 107 OG REMARK 470 GLU D 29 CG CD OE1 OE2 REMARK 470 GLU D 38 CG CD OE1 OE2 REMARK 470 GLU D 49 CG CD OE1 OE2 REMARK 470 ARG D 64 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 91 CG CD NE CZ NH1 NH2 REMARK 470 LEU D 94 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 34 N - CA - C ANGL. DEV. = 19.9 DEGREES REMARK 500 GLY B 35 N - CA - C ANGL. DEV. = 28.9 DEGREES REMARK 500 VAL B 36 N - CA - CB ANGL. DEV. = -27.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 72 -38.93 -132.04 REMARK 500 TRP B 72 -39.80 -131.68 REMARK 500 ASN B 118 21.70 80.45 REMARK 500 ILE C 106 -69.68 -91.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3N6 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE N7R B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3N7P RELATED DB: PDB DBREF 3N7R A 23 133 UNP Q16602 CALRL_HUMAN 23 133 DBREF 3N7R B 23 133 UNP Q16602 CALRL_HUMAN 23 133 DBREF 3N7R C 26 117 UNP O60894 RAMP1_HUMAN 26 117 DBREF 3N7R D 26 117 UNP O60894 RAMP1_HUMAN 26 117 SEQADV 3N7R GLY A 19 UNP Q16602 EXPRESSION TAG SEQADV 3N7R SER A 20 UNP Q16602 EXPRESSION TAG SEQADV 3N7R HIS A 21 UNP Q16602 EXPRESSION TAG SEQADV 3N7R MET A 22 UNP Q16602 EXPRESSION TAG SEQADV 3N7R GLY B 19 UNP Q16602 EXPRESSION TAG SEQADV 3N7R SER B 20 UNP Q16602 EXPRESSION TAG SEQADV 3N7R HIS B 21 UNP Q16602 EXPRESSION TAG SEQADV 3N7R MET B 22 UNP Q16602 EXPRESSION TAG SEQADV 3N7R GLY C 22 UNP O60894 EXPRESSION TAG SEQADV 3N7R SER C 23 UNP O60894 EXPRESSION TAG SEQADV 3N7R HIS C 24 UNP O60894 EXPRESSION TAG SEQADV 3N7R MET C 25 UNP O60894 EXPRESSION TAG SEQADV 3N7R GLY D 22 UNP O60894 EXPRESSION TAG SEQADV 3N7R SER D 23 UNP O60894 EXPRESSION TAG SEQADV 3N7R HIS D 24 UNP O60894 EXPRESSION TAG SEQADV 3N7R MET D 25 UNP O60894 EXPRESSION TAG SEQRES 1 A 115 GLY SER HIS MET GLU LEU GLU GLU SER PRO GLU ASP SER SEQRES 2 A 115 ILE GLN LEU GLY VAL THR ARG ASN LYS ILE MET THR ALA SEQRES 3 A 115 GLN TYR GLU CYS TYR GLN LYS ILE MET GLN ASP PRO ILE SEQRES 4 A 115 GLN GLN ALA GLU GLY VAL TYR CYS ASN ARG THR TRP ASP SEQRES 5 A 115 GLY TRP LEU CYS TRP ASN ASP VAL ALA ALA GLY THR GLU SEQRES 6 A 115 SER MET GLN LEU CYS PRO ASP TYR PHE GLN ASP PHE ASP SEQRES 7 A 115 PRO SER GLU LYS VAL THR LYS ILE CYS ASP GLN ASP GLY SEQRES 8 A 115 ASN TRP PHE ARG HIS PRO ALA SER ASN ARG THR TRP THR SEQRES 9 A 115 ASN TYR THR GLN CYS ASN VAL ASN THR HIS GLU SEQRES 1 B 115 GLY SER HIS MET GLU LEU GLU GLU SER PRO GLU ASP SER SEQRES 2 B 115 ILE GLN LEU GLY VAL THR ARG ASN LYS ILE MET THR ALA SEQRES 3 B 115 GLN TYR GLU CYS TYR GLN LYS ILE MET GLN ASP PRO ILE SEQRES 4 B 115 GLN GLN ALA GLU GLY VAL TYR CYS ASN ARG THR TRP ASP SEQRES 5 B 115 GLY TRP LEU CYS TRP ASN ASP VAL ALA ALA GLY THR GLU SEQRES 6 B 115 SER MET GLN LEU CYS PRO ASP TYR PHE GLN ASP PHE ASP SEQRES 7 B 115 PRO SER GLU LYS VAL THR LYS ILE CYS ASP GLN ASP GLY SEQRES 8 B 115 ASN TRP PHE ARG HIS PRO ALA SER ASN ARG THR TRP THR SEQRES 9 B 115 ASN TYR THR GLN CYS ASN VAL ASN THR HIS GLU SEQRES 1 C 96 GLY SER HIS MET ALA CYS GLN GLU ALA ASN TYR GLY ALA SEQRES 2 C 96 LEU LEU ARG GLU LEU CYS LEU THR GLN PHE GLN VAL ASP SEQRES 3 C 96 MET GLU ALA VAL GLY GLU THR LEU TRP CYS ASP TRP GLY SEQRES 4 C 96 ARG THR ILE ARG SER TYR ARG GLU LEU ALA ASP CYS THR SEQRES 5 C 96 TRP HIS MET ALA GLU LYS LEU GLY CYS PHE TRP PRO ASN SEQRES 6 C 96 ALA GLU VAL ASP ARG PHE PHE LEU ALA VAL HIS GLY ARG SEQRES 7 C 96 TYR PHE ARG SER CYS PRO ILE SER GLY ARG ALA VAL ARG SEQRES 8 C 96 ASP PRO PRO GLY SER SEQRES 1 D 96 GLY SER HIS MET ALA CYS GLN GLU ALA ASN TYR GLY ALA SEQRES 2 D 96 LEU LEU ARG GLU LEU CYS LEU THR GLN PHE GLN VAL ASP SEQRES 3 D 96 MET GLU ALA VAL GLY GLU THR LEU TRP CYS ASP TRP GLY SEQRES 4 D 96 ARG THR ILE ARG SER TYR ARG GLU LEU ALA ASP CYS THR SEQRES 5 D 96 TRP HIS MET ALA GLU LYS LEU GLY CYS PHE TRP PRO ASN SEQRES 6 D 96 ALA GLU VAL ASP ARG PHE PHE LEU ALA VAL HIS GLY ARG SEQRES 7 D 96 TYR PHE ARG SER CYS PRO ILE SER GLY ARG ALA VAL ARG SEQRES 8 D 96 ASP PRO PRO GLY SER HET 3N6 A 1 54 HET N7R B 1 40 HETNAM 3N6 N-{(1S)-5-AMINO-1-[(4-PYRIDIN-4-YLPIPERAZIN-1-YL) HETNAM 2 3N6 CARBONYL]PENTYL}-3,5-DIBROMO-NALPHA-{[4-(2-OXO-1,4- HETNAM 3 3N6 DIHYDROQUINAZOLIN-3 (2H)-YL)PIPERIDIN-1-YL]CARBONYL}- HETNAM 4 3N6 D-TYROSINAMIDE HETNAM N7R N-[(3R,6S)-6-(2,3-DIFLUOROPHENYL)-2-OXO-1-(2,2,2- HETNAM 2 N7R TRIFLUOROETHYL)AZEPAN-3-YL]-4-(2-OXO-2,3-DIHYDRO-1H- HETNAM 3 N7R IMIDAZO[4,5-B]PYRIDIN-1-YL)PIPERIDINE-1-CARBOXAMIDE HETSYN 3N6 OLCEGEPANT FORMUL 5 3N6 C38 H47 BR2 N9 O5 FORMUL 6 N7R C26 H27 F5 N6 O3 FORMUL 7 HOH *38(H2 O) HELIX 1 1 ILE A 32 MET A 53 1 22 HELIX 2 2 TYR A 124 ASN A 128 5 5 HELIX 3 3 LEU B 34 GLN B 54 1 21 HELIX 4 4 TYR B 124 ASN B 128 5 5 HELIX 5 5 GLN C 28 LEU C 39 1 12 HELIX 6 6 LEU C 39 GLY C 52 1 14 HELIX 7 7 GLU C 53 TRP C 56 5 4 HELIX 8 8 ASP C 58 GLY C 81 1 24 HELIX 9 9 ASN C 86 PHE C 101 1 16 HELIX 10 10 GLN D 28 LEU D 39 1 12 HELIX 11 11 LEU D 39 GLY D 52 1 14 HELIX 12 12 GLU D 53 TRP D 56 5 4 HELIX 13 13 ASP D 58 GLY D 81 1 24 HELIX 14 14 ASN D 86 PHE D 101 1 16 SHEET 1 A 2 TYR A 64 CYS A 65 0 SHEET 2 A 2 VAL A 78 ALA A 79 -1 O VAL A 78 N CYS A 65 SHEET 1 B 2 THR A 68 TRP A 69 0 SHEET 2 B 2 CYS A 74 TRP A 75 -1 O TRP A 75 N THR A 68 SHEET 1 C 2 GLU A 83 LEU A 87 0 SHEET 2 C 2 LYS A 100 ILE A 104 -1 O VAL A 101 N GLN A 86 SHEET 1 D 2 TYR B 64 CYS B 65 0 SHEET 2 D 2 VAL B 78 ALA B 79 -1 O VAL B 78 N CYS B 65 SHEET 1 E 2 THR B 68 TRP B 69 0 SHEET 2 E 2 CYS B 74 TRP B 75 -1 O TRP B 75 N THR B 68 SHEET 1 F 2 GLU B 83 LEU B 87 0 SHEET 2 F 2 LYS B 100 ILE B 104 -1 O VAL B 101 N GLN B 86 SSBOND 1 CYS A 48 CYS A 74 1555 1555 2.05 SSBOND 2 CYS A 65 CYS A 105 1555 1555 2.04 SSBOND 3 CYS A 88 CYS A 127 1555 1555 2.04 SSBOND 4 CYS B 48 CYS B 74 1555 1555 2.03 SSBOND 5 CYS B 65 CYS B 105 1555 1555 2.02 SSBOND 6 CYS B 88 CYS B 127 1555 1555 2.02 SSBOND 7 CYS C 27 CYS C 82 1555 1555 2.05 SSBOND 8 CYS C 40 CYS C 72 1555 1555 2.04 SSBOND 9 CYS C 57 CYS C 104 1555 1555 2.07 SSBOND 10 CYS D 27 CYS D 82 1555 1555 2.04 SSBOND 11 CYS D 40 CYS D 72 1555 1555 2.04 SSBOND 12 CYS D 57 CYS D 104 1555 1555 2.04 CISPEP 1 TRP C 84 PRO C 85 0 -4.17 CISPEP 2 TRP D 84 PRO D 85 0 -3.46 SITE 1 AC1 18 ILE A 41 ASP A 70 GLY A 71 TRP A 72 SITE 2 AC1 18 PHE A 92 ASP A 94 ARG A 119 TRP A 121 SITE 3 AC1 18 THR A 122 TYR A 124 ASN C 31 LEU C 39 SITE 4 AC1 18 LYS C 79 LEU C 80 ALA D 70 ASP D 71 SITE 5 AC1 18 TRP D 74 TRP D 84 SITE 1 AC2 13 ILE B 41 MET B 42 ASP B 70 GLY B 71 SITE 2 AC2 13 TRP B 72 TRP B 121 THR B 122 TYR B 124 SITE 3 AC2 13 ARG C 67 ALA C 70 ASP C 71 TRP C 74 SITE 4 AC2 13 TRP C 84 CRYST1 77.940 118.200 133.260 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012830 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008460 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007504 0.00000